Inventor profile of:

Philippe Sansonetti

City:

Paris

Country:

France

Published Applications:

25

Last publication date:

2019-12-05

Top Assignees for applications by Philippe Sansonetti

The entities that hold a legal rights for patent applications filed by inventor Sansonetti Philippe:

Recent patent applications by Sansonetti Philippe

Philippe Sansonetti from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-12-05
US20190367867A1
Chemistry; metallurgy

Method of culturing segmented filamentous bacteria in vitro

#2 | 2019-01-17
US20190017026A1
Chemistry; metallurgy

METHOD AND DEVICE FOR CONSERVING VIABLE AND FUNCTIONAL HUMAN POLYMORPHONUCLEAR NEUTROPHILS

#3 | 2017-10-19
US20170296621A1
Human necessities

NOD2-DEPENDENT PATHWAY OF CYTOPROTECTION OF STEM CELLS

#4 | 2017-02-23
US20170051253A1
Chemistry; metallurgy

METHOD AND DEVICE FOR CONSERVING VIABLE AND FUNCTIONAL HUMAN POLYMORPHONUCLEAR NEUTROPHILS

#5 | 2016-11-03
US20160318981A1
Chemistry; metallurgy

Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their nucleic acids and uses thereof

#6 | 2016-02-18
US20160047810A1
Physics

METHODS TO OBTAIN A NOVEL CLASS OF GRAM NEGATIVE BACTERIA ANTIBIOTICS WHICH TARGET AN UNKNOWN CELL DIVISION ASSOCIATED PROTEIN LOP1

#7 | 2015-12-03
US20150343018A1
Human necessities

NOD2-DEPENDENT PATHWAY OF CYTOPROTECTION OF STEM CELLS

#8 | 2015-10-15
US20150290331A1
Human necessities

Glycoconjugates and their use as potential vaccines against infection by

#9 | 2015-02-19
US20150050282A1
Chemistry; metallurgy

Glycoconjugates and use thereof as vaccine against serotype 3a and X

#10 | 2014-11-13
US20140336119A1
Chemistry; metallurgy

Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their nucleic acids and uses thereof

#11 | 2014-06-12
US20140161793A2
Human necessities

Glycoconjugates and their use as potential vaccines against infection by

#12 | 2013-09-19
US20130243751A1
Human necessities

GLYCOCONJUGATES AND THEIR USE AS POTENTIAL VACCINES AGAINST INFECTION BY SHIGELLA FLEXNERI

#13 | 2011-01-27
US20110021369A1
Chemistry; metallurgy

Single cell based reporter assay to monitor gene expression patterns with high spatio-temporal resolution

#14 | 2010-12-23
US20100322974A1
Human necessities

Targeting the histone code as a bacterial strategy for selectively modulating gene expression

#15 | 2010-09-23
US20100239584A1
Chemistry; metallurgy

Glycoconjugates and use thereof as vaccine against serotype 3a and X

#16 | 2010-08-05
US20100196391A1
Human necessities

SHIGELLA IPAD PROTEIN AND ITS USE AS A VACCINE AGAINST SHIGELLA INFECTION

#17 | 2009-12-31
US20090324646A1
Human necessities

Targeting the histone code as a bacterial strategy for selectively modulating gene expression

#18 | 2009-01-15
US20090017073A1
Physics

Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof

#19 | 2008-05-15
US20080112951A1
Human necessities

Glycoconjugates and their use as potential vaccines against infection by

#20 | 2007-04-05
US20070077254A1
Human necessities

Targeting the histone code as a bacterial strategy for selectively modulating gene expression

#21 | 2006-11-16
US20060257940A1
Chemistry; metallurgy

Transformed

#22 | 2006-09-28
US20060217319A1
Physics

Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof

#23 | 2006-07-18
US10808735
-

Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof

#24 | 2005-12-29
US20050287612A1
Human necessities

CARD-4 molecules and uses thereof

#25 | 2005-02-10
US20050031644A1
Chemistry; metallurgy

Transformed

InventorID:

443605 ⎘